Page last updated: 2024-09-04

ezetimibe and Enlarged Liver

ezetimibe has been researched along with Enlarged Liver in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chuang, JC; Lopez, AM; Posey, KS; Turley, SD	1
Cook, J; Davis, H; Hoos, L; Hwa, JJ; Tetzloff, G; van Heek, M; Zheng, S	1

Other Studies

2 other study(ies) available for ezetimibe and Enlarged Liver

Article	Year
Ezetimibe markedly attenuates hepatic cholesterol accumulation and improves liver function in the lysosomal acid lipase-deficient mouse, a model for cholesteryl ester storage disease. Biochemical and biophysical research communications, 2014, Jan-17, Volume: 443, Issue:3 Topics: Animals; Azetidines; Body Weight; Cholesterol; Cholesterol Ester Storage Disease; Disease Models, Animal; Ezetimibe; Hepatomegaly; Intestinal Mucosa; Intestines; Liver; Liver Function Tests; Male; Mice; Organ Size; Rats; Sterol Esterase; Triglycerides	2014
Ezetimibe improves high fat and cholesterol diet-induced non-alcoholic fatty liver disease in mice. European journal of pharmacology, 2008, Apr-14, Volume: 584, Issue:1 Topics: Alanine Transaminase; Animals; Anticholesteremic Agents; Azetidines; Cholesterol Esters; Cholesterol, Dietary; Dietary Fats; Disease Models, Animal; Dose-Response Relationship, Drug; Ezetimibe; Fatty Liver; Hepatomegaly; Liver; Liver Cirrhosis; Mice; Mice, Inbred C57BL; Obesity; Time Factors; Triglycerides	2008

Article

Year

Ezetimibe markedly attenuates hepatic cholesterol accumulation and improves liver function in the lysosomal acid lipase-deficient mouse, a model for cholesteryl ester storage disease.

Biochemical and biophysical research communications, 2014, Jan-17, Volume: 443, Issue:3

Topics: Animals; Azetidines; Body Weight; Cholesterol; Cholesterol Ester Storage Disease; Disease Models, Animal; Ezetimibe; Hepatomegaly; Intestinal Mucosa; Intestines; Liver; Liver Function Tests; Male; Mice; Organ Size; Rats; Sterol Esterase; Triglycerides

2014

Ezetimibe improves high fat and cholesterol diet-induced non-alcoholic fatty liver disease in mice.

European journal of pharmacology, 2008, Apr-14, Volume: 584, Issue:1

Topics: Alanine Transaminase; Animals; Anticholesteremic Agents; Azetidines; Cholesterol Esters; Cholesterol, Dietary; Dietary Fats; Disease Models, Animal; Dose-Response Relationship, Drug; Ezetimibe; Fatty Liver; Hepatomegaly; Liver; Liver Cirrhosis; Mice; Mice, Inbred C57BL; Obesity; Time Factors; Triglycerides

2008